SPIRRIT-HFPEF - DCC
SPIRRIT-HFPEF - DCC
批准号:
10018095
负责人:
Kevin J Anstrom
金额:
$15.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-15 至 2022-05-31
关键词:
AdultAffectAldosterone AntagonistsCardiovascular systemCase Report FormCause of DeathCessation of lifeClinicalClinical ResearchClinical TrialsClinical Trials Data Monitoring CommitteesClinical effectivenessCommunitiesCommunity PracticeComplexDataData Coordinating CenterData ElementData SetDevelopmentEFRACElectronic Health RecordElementsEnrollmentFosteringGoalsHealth Care CostsHealthcareHeart ArrestHeart failureHospitalizationInterventionIntervention TrialInvestigationLeadershipLeft Ventricular Ejection FractionLifeMichiganMineralocorticoid ReceptorMorbidity - disease rateNational Heart, Lung, and Blood InstituteNorth AmericaOutcomePatient RecruitmentsPatientsPharmaceutical PreparationsPlacebosPrevalencePublic HealthRandomizedRandomized Clinical TrialsRandomized Controlled TrialsRegistriesResearch InstituteResearch PersonnelScheduleSouth AmericaSpecific qualifier valueSpironolactoneStatistical Data InterpretationStructureSwedenTelephoneTestingTherapeuticTherapeutic InterventionTimeTreatment EfficacyUnited StatesUniversitiesUniversity Hospitalsaging populationbaseclinical research siteclinically relevantcompliance behaviorcostdata managementdata qualitydesigneffective therapyevidence baseexperiencefollow-upheart functionheart preservationhospital readmissionimprovedmortalitynovelopen labelpatient populationpragmatic trialpreservationprimary endpointprimary outcomeprospectiverandomized trialsecondary endpointsecondary outcomestandard of caresymptomatic improvementtooltreatment as usual
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved
Ejection Fraction (SPIRRIT-HFpEF) is a pragmatic, registry-based randomized clinical trial that proposes to
evaluate the clinical effectiveness of spironolactone versus usual care. The primary hypothesis of SPIRRIT-
HFpEF is that treatment with spironolactone will reduce cardiovascular mortality compared with usual care.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Back Pain Consortium (BACPAC) Research Program Data Integration, Algorithm Development and Operations Management Center
-
批准号:10400459
-
项目类别:
-
资助金额:$41.64万
-
财政年份:2019
-
负责人:Kevin J Anstrom
-
依托单位:
Back Pain Consortium (BACPAC) Research Program Data Integration, Algorithm Development and Operations Management Center
-
批准号:10396871
-
项目类别:
-
资助金额:$400.0万
-
财政年份:2019
-
负责人:Kevin J Anstrom
-
依托单位:
Back Pain Consortium (BACPAC) Research Program Data Integration, Algorithm Development and Operations Management Center
-
批准号:9898044
-
项目类别:
-
资助金额:$5178.13万
-
财政年份:2019
-
负责人:Kevin J Anstrom
-
依托单位:
TRANSFORM-HF DCC
-
批准号:9768524
-
项目类别:
-
资助金额:$72.87万
-
财政年份:2017
-
负责人:Kevin J Anstrom
-
依托单位:
TRANSFORM-HF DCC
-
批准号:9310535
-
项目类别:
-
资助金额:$84.25万
-
财政年份:2017
-
负责人:Kevin J Anstrom
-
依托单位:
SPIRRIT-HFPEF - DCC
-
批准号:9217488
-
项目类别:
-
资助金额:$33.42万
-
财政年份:2017
-
负责人:Kevin J Anstrom
-
依托单位:
Trial to Assess Chelation Therapy 2 (TACT2) DCC
-
批准号:9182074
-
项目类别:
-
资助金额:$38.98万
-
财政年份:2015
-
负责人:Kevin J Anstrom
-
依托单位:
Trial to Assess Chelation Therapy 2 (TACT2) DCC
-
批准号:9144715
-
项目类别:
-
资助金额:$151.2万
-
财政年份:2015
-
负责人:Kevin J Anstrom
-
依托单位:
Trial to Assess Chelation Therapy 2 (TACT2) DCC Supplemental Bridge Funding
-
批准号:10393120
-
项目类别:
-
资助金额:$107.56万
-
财政年份:2015
-
负责人:Kevin J Anstrom
-
依托单位:
Study of Co-trimoxazole and Proton Pump Inhibition Using Pragmatic Design in Idiopathic Pulmonary Fibrosis - CleanUP-IPF
-
批准号:8956219
-
项目类别:
-
资助金额:$39.46万
-
财政年份:2015
-
负责人:Kevin J Anstrom
-
依托单位:
Trial to Assess Chelation Therapy 2 (TACT2) DCC Competing Renewal
-
批准号:10371930
-
项目类别:
-
资助金额:$243.93万
-
财政年份:2015
-
负责人:Kevin J Anstrom
-
依托单位:
Study of Co-trimoxazole and Proton Pump Inhibition Using Pragmatic Design in Idiopathic Pulmonary Fibrosis - CleanUP-IPF
-
批准号:9344730
-
项目类别:
-
资助金额:$15.66万
-
财政年份:2015
-
负责人:Kevin J Anstrom
-
依托单位:
Trial to Assess Chelation Therapy 2 (TACT2) DCC Competing Renewal
-
批准号:10590584
-
项目类别:
-
资助金额:$212.07万
-
财政年份:2015
-
负责人:Kevin J Anstrom
-
依托单位:
GUIDing Evidence Based Therapy Using Biomarker Intensified Treatment (DCC)
-
批准号:8895089
-
项目类别:
-
资助金额:$77.83万
-
财政年份:2012
-
负责人:Kevin J Anstrom
-
依托单位:
GUIDing Evidence Based Therapy Using Biomarker Intensified Treatment (DCC)
-
批准号:8479427
-
项目类别:
-
资助金额:$58.91万
-
财政年份:2012
-
负责人:Kevin J Anstrom
-
依托单位:
GUIDing Evidence Based Therapy Using Biomarker Intensified Treatment (DCC)
-
批准号:9066530
-
项目类别:
-
资助金额:$87.98万
-
财政年份:2012
-
负责人:Kevin J Anstrom
-
依托单位:
GUIDing Evidence Based Therapy Using Biomarker Intensified Treatment (DCC)
-
批准号:8235667
-
项目类别:
-
资助金额:$60.54万
-
财政年份:2012
-
负责人:Kevin J Anstrom
-
依托单位:
Idiopathic Pulmonary Fibrosis Clinical Research Network
-
批准号:8720867
-
项目类别:
-
资助金额:$44.5万
-
财政年份:2009
-
负责人:Kevin J Anstrom
-
依托单位:
Heart Failure Clinical Research Network Coordinating Center
-
批准号:8796126
-
项目类别:
-
资助金额:$544.72万
-
财政年份:2006
-
负责人:Kevin J Anstrom
-
依托单位:
Heart Failure Clinical Research Network Coordinating Center
-
批准号:8403733
-
项目类别:
-
资助金额:$474.59万
-
财政年份:2006
-
负责人:Kevin J Anstrom
-
依托单位:
海外基金